Blackstone Inc
RNAM

Blackstone Inc’s Avidity Biosciences RNAM Stock Holding History

Blackstone Inc’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,470
Closed -$1.55M – 474
2025
Q4 		$1.55M Buy
+21,470
New +$1.39M 0.01% 201

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Blackstone Inc's RNAM Position: Q1 2026 in Review

Blackstone Inc sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 21,470 shares — an estimated $1.55M sold.

Blackstone Inc first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $1.55M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Blackstone Inc reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Blackstone Inc sold 21,470 Avidity Biosciences shares in Q1 2026, an estimated $1.55M.
  • Blackstone Inc first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Blackstone Inc's Avidity Biosciences position peaked at $1.55M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Blackstone Inc's 13F filing for Q1 2026, filed 15 May 2026.